Extranodal NK/T-cell lymphoma: Toward the identification of clinical molecular targets

Journal of Biomedicine and Biotechnology

Volumn 2011, Issue , 2011, Pages

  Schmitt, Christian ^a,b,c   Sako, Nouhoum ^a,b   Bagot, Martine ^a,b   Huang, Yenlin ^d   Gaulard, Philippe ^e,f,g   Bensussan, Armand ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c SAINT LOUIS HOSPITAL   (France)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^e INSERM U955   (France)

^f FACULTÉ DE MÉDECINE   (France)

^g HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; APOPTOSIS; ASIA; CANCER SURVIVAL; CENTRAL AMERICA; CHROMOSOME ANALYSIS; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; GENOME ANALYSIS; HUMAN; NATURAL KILLER CELL; NK T CELL LYMPHOMA; NONHODGKIN LYMPHOMA; PATHOGENESIS; PROGNOSIS; RARE DISEASE; REVIEW; SIGNAL TRANSDUCTION; SOUTH AMERICA; CYTOTOXICITY; EPSTEIN BARR VIRUS INFECTION; GENETICS; IMMUNOLOGY; METABOLISM; NATURAL KILLER T CELL; PATHOLOGY; VIROLOGY;

HUMAN HERPESVIRUS 4;

VIRUS PROTEIN;

CYTOTOXICITY, IMMUNOLOGIC; EPSTEIN-BARR VIRUS INFECTIONS; HUMANS; LYMPHOMA, EXTRANODAL NK-T-CELL; NATURAL KILLER T-CELLS; SIGNAL TRANSDUCTION; VIRAL PROTEINS;

EID: 79959337286     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2011/790871     Document Type: Review

References (109)

1. Swerdlow S., Campo E., Harris N., Jaffe E., Pileri S. H. S., WHO Classification of Tumors of the Haematopoietic and Lymphoid Tissues 2008 Lyon, France International Agency of Research on Cancer (IARC)
2. Au W. Y., Weisenburger D. D., Intragumtornchai T., Nakamura S., Kim W. S., Sng I., Vose J., Armitage J. O., Liang R., Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project Blood 2009 113 17 3931 3937
3. Chan J. K. C., Sin V. C., Wong K. F., Ng C. S., Tsang W. Y. W., Chan C. H., Cheung M. M. C., Lau W. H., Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm Blood 1997 89 12 4501 4513 (Pubitemid 27260260)
4. Lee J., Yeon H. P., Won S. K., Lee S. S., Ryoo B. Y., Sung H. Y., Keon W. P., Jung H. K., Joon OH. P., Se H. L., Kim K., Chul W. J., Young S. P., Im Y. H., Won KI. K., Lee M. H., Ko Y. H., Yong C. A., Park K., Extranodal nasal type NK/T-cell Lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy European Journal of Cancer 2005 41 10 1402 1408 (Pubitemid 40826463)
5. Takahashi E., Asano N., Li C., Tanaka T., Shimada K., Shimada S., Yoshino T., Kojima M., Hara K., Eimoto T., Nakamura S., Nodal T/NK-cell lymphoma of nasal type: a clinicopathological study of six cases Histopathology 2008 52 5 585 596 (Pubitemid 351442669)
6. Aviles A., Rodriguez L., Guzman R., Talavera A., Garcia E. L., Diaz-Maqueo J. C., Angiocentric T-cell lymphoma of the nose, paranasal sinuses and hard palate Hematological Oncology 1992 10 3-4 141 147
7. Chan J. K. C., Ng C. S., Hui P. K., Lo S. T. H., Lau W. H., Angiocentric T-cell lymphoma of the skin: an aggressive lymphoma distinct from mycosis fungoides American Journal of Surgical Pathology 1988 12 11 861 876
8. Ishii Y., Yamanaka N., Ogawa K., Nasal T-cell lymphoma as a type of so-called lethal midline granuloma Cancer 1982 50 11 2336 2344 (Pubitemid 13244170)
9. Harris N. L., Jaffe E. S., Stein H., Banks P. M., Chan J. K. C., Cleary M. L., Delsol G., De Wolf-Peeters C., Falini B., Gatter K. C., Grogan T. M., Isaacson P. G., Knowles D. M., Mason D. Y., Muller-Hermelink H. K., Pileri S. A., Piris M. A., Ralfkiaer E., Warnke R. A., A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group Blood 1994 84 5 1361 1392 (Pubitemid 24273002)
10. Emile J. F., Boulland M. L., Haioun C., Kanavaros P., Petrella T., Delfau-Larue M. H., Bensussan A., Farcet J. P., Gaulard P., CD5-CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas Blood 1996 87 4 1466 1473 (Pubitemid 26056911)
11. Suzumiya J., Takeshita M., Kimura N., Kikuchi M., Uchida T., Hisano S., Eura Y., Kozuru M., Nomura Y., Tomita K., Komiyama S., Okumura M., Expression of adult and fetal natural killer cell markers in sinonasal lymphomas Blood 1994 83 8 2255 2260 (Pubitemid 24112738)
12. Kanavaros P., Lescs M. C., Briere J., Divine M., Galateau F., Joab I., Bosq J., Farcet J. P., Reyes F., Gaulard P., Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus Blood 1993 81 10 2688 2695 (Pubitemid 23147574)
13. Ruskova A. K., Thula R., Chan G. T. C., Aggressive natural killer-cell leukemia: report of five cases and review of the literature Leukemia and Lymphoma 2004 45 12 2427 2438 (Pubitemid 40081185)
14. Chiang A. K. S., Wong K. Y., Liang A. C. T., Srivastava G., Comparative analysis of Epstein-Barr virus gene polymorphisms in nasal T/NK-cell lymphomas and normal nasal tissues: implications on virus strain selection in malignancy International Journal of Cancer 1999 80 3 356 364 (Pubitemid 29019620)
15. Minarovits J., Hu L. F., Imai S., Harabuchi Y., Kataura A., Minarovits-Kormuta S., Osato T., Klein G., Clonality, expression and methylation patterns of the Epstein-Barr virus genomes in lethal midline granulomas classified as peripheral angiocentric T cell lymphomas Journal of General Virology 1994 75 1 77 84 (Pubitemid 24033982)
16. Jaccard A., Gachard N., Marin B., Rogez S., Audrain M., Suarez F., Tilly H., Morschhauser F., Thieblemont C., Ysebaert L., Devidas A., Petit B., De Leval L., Gaulard P., Feuillard J., Bordessoule D., Hermine O., Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study Blood 2011 117 6 1834 1839
17. Anderson J. R., Armitage J. O., Weisenburger D. D., Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations Annals of Oncology 1998 9 7 717 720 (Pubitemid 28394156)
18. Kohrt H., Advani R., Extranodal natural killer/T-cell lymphoma: current concepts in biology and treatment biology and treatment Leukemia and Lymphoma 2009 50 11 1773 1784
19. Vose J. M., Neumann M., Harris M. E., International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes international T-cell lymphoma project Journal of Clinical Oncology 2008 26 25 4124 4130
20. Bossard C., Belhadj K., Reyes F., Martin-Garcia N., Berger F., Kummer J. A., Brire J., Baglin A. C., Cheze S., Bosq J., Ribrag V., Gisselbrecht C., Mounier N., Gaulard P., Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials Blood 2007 109 5 2183 2189 (Pubitemid 46348221)
21. Kim T. M., Lee S. Y., Jeon Y. K., Ryoo B. Y., Cho G. J., Hong Y. S., Kim H. J., Kim S. Y., Kim C. S., Kim S., Kim J. S., Sohn S. K., Song H. H., Lee J. L., Kang Y. K., Yim C. Y., Lee W. S., Yuh Y. J., Kim C. W., Heo D. S., Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group Annals of Oncology 2008 19 8 1477 1484
22. Yong W., Zheng W., Zhu J., Zhang Y., Wang X., Xie Y., Lin N., Xu BO., Lu A., Li J., L-asparaginase in the treatment of refractory and relapsed extranodal NK/ T-cell lymphoma, nasal type Annals of Hematology 2009 88 7 647 652
23. Reyes V. E. Jr., Al-Saleem T., Robu V. G., Smith M. R., Extranodal NK/T-cell lymphoma nasal type: efficacy of pegaspargase. Report of two patients from the United Sates and review of literature Leukemia Research 2010 34 1 e50 e54
24. Huang Y., De Reynis A., De Leval L., Ghazi B., Martin-Garcia N., Travert M., Bosq J., Brire J., Petit B., Thomas E., Coppo P., Marafioti T., Emile J. F., Delfau-Larue M. H., Schmitt C., Gaulard P., Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type Blood 2010 115 6 1226 1237
25. Iqbal J., Weisenburger D. D., Chowdhury A., Tsai M. Y., Srivastava G., Greiner T. C., Kucuk C., Deffenbacher K., Vose J., Smith L., Au W. Y., Nakamura S., Seto M., Delabie J., Berger F., Loong F., Ko Y.-H., Sng I., Liu X., Loughran T. P., Armitage J., Chan W. C., Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro Leukemia 2011 25 2 348 358
26. Nagato T., Kobayashi H., Kishibe K., Takahara M., Ogino T., Ishii H., Oikawa K., Aoki N., Sato K., Kimura S., Shimizu N., Tateno M., Harabuchi Y., Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients Clinical Cancer Research 2005 11 23 8250 8257 (Pubitemid 41746934)
27. Nakashima Y., Tagawa H., Suzuki R., Karnan S., Karube K., Ohshima K., Muta K., Nawata H., Morishima Y., Nakamura S., Seto M., Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal NK/T-cell lymphoma, nasal type Genes Chromosomes and Cancer 2005 44 3 247 255 (Pubitemid 41397093)
28. Ng S.-B., Selvarajan V., Huang G., Zhou J., Feldman A. L., Law M., Kwong Y.-L., Shimizu N., Kagami Y., Aozasa K., Salto-Tellez M., Chng W.-J., Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling Journal of Pathology 2011 223 4 496 510
29. Oka T., Yoshino T., Hayashi K., Ohara N., Nakanishi T., Yamaai Y., Hiraki A., Aoki Sogawa C., Kondo E., Teramoto N., Takahashi K., Tsuchiyama J., Akagi T., Reduction of hematopoietic cell-specific tyrosine phosphatase SHP-1 gene expression in natural killer cell lymphoma and various types of lymphomas/leukemias: combination analysis with cDNA expression array and tissue microarray American Journal of Pathology 2001 159 4 1495 1505 (Pubitemid 32947978)
30. Zhang Y., Ohyashiki J. H., Takaku T., Shimizu N., Ohyashiki K., Transcriptional profiling of Epstein-Barr virus (EBV) genes and host cellular genes in nasal NK/T-cell lymphoma and chronic active EBV infection British Journal of Cancer 2006 94 4 599 608 (Pubitemid 43289766)
31. Heslop H. E., Slobod K. S., Pule M. A., Hale G. A., Rousseau A., Smith C. A., Bollard C. M., Liu H., Wu M. F., Rochester R. J., Amrolia P. J., Hurwitz J. L., Brenner M. K., Rooney C. M., Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients Blood 2010 115 5 925 935
32. Chiang A. K. S., Tao Q., Srivastava G., Ho F. C. S., Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease International Journal of Cancer 1996 68 3 285 290 (Pubitemid 26384128)
33. Bollard C. M., Gottschalk S., Leen A. M., Weiss H., Straathof K. C., Carrum G., Khalil M., Wu M. F., Huls M. H., Chang C. C., Gresik M. V., Gee A. P., Brenner M. K., Rooney C. M., Heslop H. E., Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer Blood 2007 110 8 2838 2845 (Pubitemid 350006936)
34. Fox C. P., Haigh T. A., Taylor G. S., Long H. M., Lee S. P., Shannon-Lowe C., O'Connor S., Bollard C. M., Iqbal J., Chan W. C., Rickinson A. B., Bell A. I., Rowe M., A novel latent membrane 2 transcript expressed in Epstein-Barr virus-positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy Blood 2010 116 19 3695 3704
35. Kaneko T., Fukuda J., Yoshihara T., Zheng H., Mori S., Mizoguchi H., Oshimi K., Nasal natural killer (NK) cell lymphoma: report of a case with activated NK cells containing Epstein-Barr virus and expressing CD21 antigen, and comparative studies of their phenotype and cytotoxicity with normal NK cells British Journal of Haematology 1995 91 2 355 361
36. Tabiasco J., Vercellone A., Meggetto F., Hudrisier D., Brousset P., Fourni J. J., Acquisition of viral receptor by NK cells through immunological synapse Journal of Immunology 2003 170 12 5993 5998 (Pubitemid 36682579)
37. Kimura H., Hoshino Y., Kanegane H., Tsuge I., Okamura T., Kawa K., Morishima T., Clinical and virologic characteristics of chronic active Epstein-Barr virus infection Blood 2001 98 2 280 286
38. Straus S. E., The chronic mononucleosis syndrome Journal of Infectious Diseases 1988 157 3 405 412 (Pubitemid 18071434)
39. Cohen J. I., Kimura H., Nakamura S., Ko Y. H., Jaffe E. S., Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008 Annals of Oncology 2009 20 9 1472 1482
40. Boulland M. L., Meignin V., Leroy-Viard K., Copie-Bergman C., Brire J., Touitou R., Kanavaros P., Gaulard P., Human interleukin-10 expression in T/natural killer-cell lymphomas: association with anaplastic large cell lymphomas and nasal natural killer- cell lymphomas American Journal of Pathology 1998 153 4 1229 1237 (Pubitemid 28465846)
41. Teruya-Feldstein J., Jaffe E. S., Burd P. R., Kanegane H., Kingma D. W., Wilson W. H., Longo D. L., Tosato G., The role of Mig, the monokine induced by interferon-, and IP-10, the interferon- -inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease Blood 1997 90 10 4099 4105 (Pubitemid 27484065)
42. Kanavaros P., Boulland M. L., Petit B., Arnulf B., Gaulard P., Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or T phenotype, anaplastic morphology and CD30 expression Leukemia and Lymphoma 2000 38 3-4 317 326 (Pubitemid 30303665)
43. Vivier E., Tomasello E., Baratin M., Walzer T., Ugolini S., Functions of natural killer cells Nature Immunology 2008 9 5 503 510 (Pubitemid 351560519)
44. Schmitt C., Ghazi B., Bensussan A., NK cells and surveillance in humans Reproductive BioMedicine Online 2008 16 2 192 201 (Pubitemid 351291965)
45. Parham P., MHC class I molecules and KIRS in human history, health and survival Nature Reviews Immunology 2005 5 3 201 214 (Pubitemid 40364822)
46. Suto Y., Maenaka K., Yabe T., Hirai M., Tokunaga K., Tadokoro K., Juji T., Chromosomal localization of the human natural killer cell class I receptor family genes to 19q13.4 by fluorescence in situ hybridization Genomics 1996 35 1 270 272 (Pubitemid 26236184)
47. Khakoo S. I., Carrington M., KIR and disease: a model system or system of models? Immunological Reviews 2006 214 1 186 201 (Pubitemid 44707911)
48. Haedicke W., Ho F. C. S., Chott A., Moretta L., Rdiger T., Ott G., Mller-Hermelink H. K., Expression of CD94/NKG2A and killer immunoglobulin-like receptors in NK cells and a subset of extranodal cytotoxic T-cell lymphomas Blood 2000 95 11 3628 3630 (Pubitemid 30428502)
49. Lin C. W., Lee W. H., Chang C. L., Yang J. Y., Hsu S. M., Restricted killer cell immunoglobulin-like receptor repertoire without T-cell receptor rearrangement supports a true natural killer-cell lineage in a subset of sinonasal lymphomas American Journal of Pathology 2001 159 5 1671 1679
50. Lundell R., Hartung L., Hill S., Perkins S. L., Bahler D. W., T-cell large granular lymphocyte leukemias have multiple phenotypic abnormalities involving pan-T-cell antigens and receptors for MHC molecules American Journal of Clinical Pathology 2005 124 6 937 946 (Pubitemid 41740195)
51. Dalloul A., Laroche L., Bagot M., Mossalayi M. D., Fourcade C., Thacker D. J., Hogge D. E., Merle-Beral H., Debre P., Schmitt C., Interleukin-7 is a growth factor for Sezary lymphoma cells Journal of Clinical Investigation 1992 90 3 1054 1060
52. Ortonne N., Le Gouvello S., Mansour H., Poillet C., Martin N., Delfau-Larue M. H., Leroy K., Farcet J. P., Bagot M., Bensussan A., CD158K/KIR3DL2 transcript detection in lesional skin of patients with erythroderma is a tool for the diagnosis of Szary syndrome Journal of Investigative Dermatology 2008 128 2 465 472
53. Poszepczynska-Guign E., Schiavon V., D'Incan M., Echchakir H., Musette P., Ortonne N., Boumsell L., Moretta A., Bensussan A., Bagot M., CD158k/KIR3DL2 is a new phenotypic marker of sezary cells: relevance for the diagnosis and follow-up of sezary syndrome Journal of Investigative Dermatology 2004 122 3 820 823 (Pubitemid 38471353)
54. Takei F., McQueen K. L., Maeda M., Wilhelm B. T., Lohwasser S., Lian R. H., Mager D. L., Ly49 and CD94/NKG2: developmentally regulated expression and evolution Immunological Reviews 2001 181 90 103 (Pubitemid 32703398)
55. Lin C. W., Chen Y. H., Chuang Y. C., Liu T. Y., Hsu S. M., CD94 transcripts imply a better prognosis in nasal-type extranodal NK/T-cell lymphoma Blood 2003 102 7 2623 2631
56. Fernandez L. A., Pope B., Lee C., Zayed E., Aggressive natural killer cell leukemia in an adult with establishment of an NK cell line Blood 1986 67 4 925 930 (Pubitemid 16116398)
57. Koizumi S., Seki H., Tachinami T., Malignant clonal expansion of large granular lymphocytes with a Leu-11+, Leu-7- surface phenotype: in vitro responsiveness of malignant cells to recombinant human interleukin 2 Blood 1986 86 5 1065 1073 (Pubitemid 17186382)
58. Froelich C. J., Dixit V. M., Yang X., Lymphocyte granule-mediated apoptosis: matters of viral mimicry and deadly proteases Immunology Today 1998 19 1 30 36 (Pubitemid 28078606)
59. Barrie M. B., Stout H. W., Abougergi M. S., Miller B. C., Thiele D. L., Antiviral cytokines induce hepatic expression of the granzyme B inhibitors, proteinase inhibitor 9 and serine proteinase inhibitor 6 Journal of Immunology 2004 172 10 6453 6459 (Pubitemid 38621255)
60. Bladergroen B. A., Meijer C. J. L. M., Ten Berge R. L., Hack C. E., Muris J. J. F., Dukers D. F., Chott A., Kazama Y., Oudejans J. J., Van Berkum O., Kummer J. A., Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system? Blood 2002 99 1 232 237
61. Ng C. S., Lo S. T. H., Chan J. K. C., Chan W. C., CD56+ putative natural killer cell lymphomas: production of cytolytic effectors and related proteins mediating tumor cell apoptosis? Human Pathology 1997 28 11 1276 1282 (Pubitemid 27492827)
62. Aozasa K., Takakuwa T., Hongyo T., Yang W. I., Nasal NK/T-cell lymphoma: epidemiology and pathogenesis International Journal of Hematology 2008 87 2 110 117
63. Takakuwa T., Dong Z., Nakatsuka S., Kojya S., Harabuchi Y., Yang W. I., Nagata S., Aozasa K., Frequent mutations of Fas gene in nasal NK/T cell lymphoma Oncogene 2002 21 30 4702 4705 (Pubitemid 34833148)
64. Yamaguchi M., Kita K., Miwa H., Nishii K., Oka K., Ohno T., Shirakawa S., Fukumoto M., Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells Cancer 1995 76 11 2351 2356
65. Ko Y. H., Ree H. J., Kim W. S., Choi W. H., Moon W. S., Kim S. W., Clinicopathologic and genotypic study of extranodal nasal-type natural killer/T-cell lymphoma and natural killer precursor lymphoma among Koreans Cancer 2000 89 10 2106 2116
66. Ko Y. H., Choi K. E., Han J. H., Kim J. M., Ree H. J., Comparative genomic hybridization study of nasal-type NK/T-cell lymphoma Communications in Clinical Cytometry 2001 46 2 85 91 (Pubitemid 32423458)
67. Siu L. L., Chan V., Chan J. K. C., Wong K. F., Liang R., Kwong Y. L., Consistent patterns of allelic loss in natural killer cell lymphoma American Journal of Pathology 2000 157 6 1803 1809
68. Siu L. L., Wong K. F., Chan J. K. C., Kwong Y. L., Comparative genomic hybridization analysis of natural killer cell lymphoma/leukemia: recognition of consistent patterns of genetic alterations American Journal of Pathology 1999 155 5 1419 1425
69. Sun H. S., Su I. J., Lin Y. C., Chen J. S., Fang S. Y., A 2.6 Mb interval on chromosome 6q25.2-q25.3 is commonly deleted in human nasal natural killer/T-cell lymphoma British Journal of Haematology 2003 122 4 590 599 (Pubitemid 36995213)
70. Yoon J., Ko Y. H., Deletion mapping of the long arm of chromosome 6 in peripheral T and NK cell lymphomas Leukemia and Lymphoma 2003 44 12 2077 2082 (Pubitemid 37369647)
71. Iqbal J., Kucuk C., deLeeuw R. J., Srivastava G., Tam W., Geng H., Klinkebiel D., Christman J. K., Patel K., Cao K., Shen L., Dybkaer K., Tsui I. F. L., Ali H., Shimizu N., Au W. Y., Lam W. L., Chan W. C., Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies Leukemia 2009 23 6 1139 1151
72. Kuma A., Hatano M., Matsui M., Yamamoto A., Nakaya H., Yoshimori T., Ohsumi Y., Tokuhisa T., Mizushima N., The role of autophagy during the early neonatal starvation period Nature 2004 432 7020 1032 1036 (Pubitemid 40052234)
73. Hippert M. M., O'Toole P. S., Thorburn A., Autophagy in cancer: good, bad, or both? Cancer Research 2006 66 19 9349 9351
74. Ray M. E., Wistow G., Su Y. A., Meltzer P. S., Trent J. M., AIM1, a novel non-lens member of the -crystallin superfamily, is associated with the control of tumorigenicity in human malignant melanoma Proceedings of the National Academy of Sciences of the United States of America 1997 94 7 3229 3234 (Pubitemid 27157293)
75. Martins G. A., Cimmino L., Shapiro-Shelef M., Szabolcs M., Herron A., Magnusdottir E., Calame K., Transcriptional repressor Blimp-1 regulates T cell homeostasis and function Nature Immunology 2006 7 5 457 465
76. Turner C. A. Jr., Mack D. H., Davis M. M., Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells Cell 1994 77 2 297 306 (Pubitemid 24138626)
77. Pasqualucci L., Compagno M., Houldsworth J., Monti S., Grunn A., Nandula S. V., Aster J. C., Murty V. V., Shipp M. A., Dalla-Favera R., Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma Journal of Experimental Medicine 2006 203 2 311 317 (Pubitemid 43290840)
78. Semenza G. L., Hif-1 and human disease: one highly involved factor Genes and Development 2000 14 16 1983 1991 (Pubitemid 30637348)
79. Jost P. J., Ruland J., Aberrant NF- B signaling in lymphoma: mechanisms, consequences, and therapeutic implications Blood 2007 109 7 2700 2707 (Pubitemid 46482061)
80. Darnell J. E. Jr., Kerr I. M., Stark G. R., Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins Science 1994 264 5164 1415 1421 (Pubitemid 24217131)
81. Zhang Q., Raghunath P. N., Xue L., Majewski M., Carpentieri D. F., Odum N., Morris S., Skorski T., Wasik M. A., Multilevel dysregulation of STAT3 activation in anaplastic lymphoma kinase-positive T/null-cell lymphoma Journal of Immunology 2002 168 1 466 474 (Pubitemid 34014150)
82. Coppo P., Gouilleux-Gruart V., Huang Y., Bouhlal H., Bouamar H., Bouchet S., Perrot C., Vieillard V., Dartigues P., Gaulard P., Agbalika F., Douay L., Lassoued K., Gorin N. C., STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphoma Leukemia 2009 23 9 1667 1678
83. Piccaluga P. P., Agostinelli C., Califano A., Rossi M., Basso K., Zupo S., Went P., Klein U., Zinzani P. L., Baccarani M., Favera R. D., Pileri S. A., Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets Journal of Clinical Investigation 2007 117 3 823 834 (Pubitemid 46348541)
84. Wang T., Niu G., Kortylewski M., Burdelya L., Shain K., Zhang S., Bhattacharya R., Gabrilovich D., Heller R., Coppola D., Dalton W., Jove R., Pardoll D., Yu H., Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells Nature Medicine 2004 10 1 48 54 (Pubitemid 38524698)
85. Rotin D., Kumar S., Physiological functions of the HECT family of ubiquitin ligases Nature Reviews Molecular Cell Biology 2009 10 6 398 409
86. Schmitz R., Hansmann M. L., Bohle V., Martin-Subero J. I., Hartmann S., Mechtersheimer G., Klapper W., Vater I., Giefing M., Gesk S., Stanelle J., Siebert R., Kppers R., TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma Journal of Experimental Medicine 2009 206 5 981 989
87. Quintanilla-Martinez L., Kremer M., Keller G., Nathrath M., Gamboa-Dominguez A., Meneses A., Luna-Contreras L., Cabras A., Hoefler H., Mohar A., Fend F., p53 mutations in nasal natural killer/t-cell lymphoma from mexico: association with large cell morphology and advanced disease American Journal of Pathology 2001 159 6 2095 2105 (Pubitemid 33104264)
88. Li M., Chen D., Shiloh A., Luo J., Nikolaev A. Y., Qin J., Gu W., Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization Nature 2002 416 6881 648 653 (Pubitemid 34406767)
89. Kimura M., Matsuda Y., Eki T., Yoshioka T., Okumura K., Hanaoka F., Okano Y., Assignment of STK6 to human chromosome 20q13.2→q13.1 and a pseudogene STK6P to 1q41→q42 Cytogenetics and Cell Genetics 1997 79 3-4 201 203 (Pubitemid 28211721)
90. Zhang L., Anglesio M. S., O'Sullivan M., Zhang F., Yang GE., Sarao R., Nghiem M. P., Cronin S., Hara H., Melnyk N., Li L., Wada T., Liu P. P., Farrar J., Arceci R. J., Sorensen P. H., Penninger J. M., The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers Nature Medicine 2007 13 9 1060 1069 (Pubitemid 47517503)
91. Anglesio M. S., Evdokimova V., Melnyk N., Zhang L., Fernandez C. V., Grundy P. E., Leach S., Marra M. A., Brooks-Wilson A. R., Penninger J., Sorensen P. H. B., Differential expression of a novel ankyrin containing E3 ubiquitin-protein ligase, Hace1, in sporadic Wilms' tumor versus normal kidney Human Molecular Genetics 2004 13 18 2061 2074 (Pubitemid 39377829)
92. Zhao J., Zhang Z., Vucetic Z., Soprano K. J., Soprano D. R., HACE1: a novel repressor of RAR transcriptional activity Journal of Cellular Biochemistry 2009 107 3 482 493
93. Bowman T., Garcia R., Turkson J., Jove R., STATs in oncogenesis Oncogene 2000 19 21 2474 2488 (Pubitemid 30339203)
94. Bromberg J. F., Wrzeszczynska M. H., Devgan G., Zhao Y., Pestell R. G., Albanese C., Darnell J. E., Stat3 as an oncogene Cell 1999 98 3 295 303 (Pubitemid 29380565)
95. Chiarle R., Simmons W. J., Cai H., Dhall G., Zamo A., Raz R., Karras J. G., Levy D. E., Inghirami G., Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target Nature Medicine 2005 11 6 623 629 (Pubitemid 40868302)
96. Zamo A., Chiarle R., Piva R., Howes J., Fan Y., Chilosi M., Levy D. E., Inghirami G., Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death Oncogene 2002 21 7 1038 1047 (Pubitemid 34174516)
97. Yu H., Kortylewski M., Pardoll D., Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment Nature Reviews Immunology 2007 7 1 41 51 (Pubitemid 46020826)
98. Kortylewski M., Kujawski M., Wang T., Wei S., Zhang S., Pilon-Thomas S., Niu G., Kay H., Mul J., Kerr W. G., Jove R., Pardoll D., Yu H., Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity Nature Medicine 2005 11 12 1314 1321 (Pubitemid 41752912)
99. Zou C., Ma J., Wang X., Guo L., Zhu Z., Stoops J., Eaker A. E., Johnson C. J., Strom S., Michalopoulos G. K., DeFrances M. C., Zarnegar R., Lack of Fas antagonism by Met in human fatty liver disease Nature Medicine 2007 13 9 1078 1085 (Pubitemid 47517506)
100. Hadland B. K., Manley N. R., Su D. M., Longmore G. D., Moore C. L., Wolfe M. S., Schroeter E. H., Kopan R., -secretase inhibitors repress thymocyte development Proceedings of the National Academy of Sciences of the United States of America 2001 98 13 7487 7491 (Pubitemid 32567975)
101. Palomero T., Sulis M. L., Cortina M., Real P. J., Barnes K., Ciofani M., Caparros E., Buteau J., Brown K., Perkins S. L., Bhagat G., Agarwal A. M., Basso G., Castillo M., Nagase S., Cordon-Cardo C., Parsons R., Ziga-Pflcker J. C., Dominguez M., Ferrando A. A., Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia Nature Medicine 2007 13 10 1203 1210 (Pubitemid 47530629)
102. Chanudet E., Ye H., Ferry J., Bacon C. M., Adam P., Mller-Hermelink H. K., Radford J., Pileri S. A., Ichimura K., Collins V. P., Hamoudi R. A., Nicholson A. G., Wotherspoon A. C., Isaacson P. G., Du M. Q., A20 deletion is associated with copy number gain at the TNFAIBIC locus and occurs preferentially in translocation-negative MALT lymphoma of the ocular adnexa and salivary glands Journal of Pathology 2009 217 3 420 430
103. Siu L. L., Chan J. K. C., Wong K. F., Kwong Y. L., Specific patterns of gene methylation in natural killer cell lymphomas: p73 is consistently involved American Journal of Pathology 2002 160 1 59 66 (Pubitemid 34052266)
104. Rouget-Quermalet V., Giustiniani J., Marie-Cardine A., Beaud G., Besnard F., Loyaux D., Ferrara P., Leroy K., Shimizu N., Gaulard P., Bensussan A., Schmitt C., Protocadherin 15 (PCDH15): a new secreted isoform and a potential marker for NK/T cell lymphomas Oncogene 2006 25 19 2807 2811
105. Ito M., Maruyama T., Saito N., Koganei S., Yamamoto K., Matsumoto N., Killer cell lectin-like receptor G1 binds three members of the classical cadherin family to inhibit NK cell cytotoxicity Journal of Experimental Medicine 2006 203 2 289 295 (Pubitemid 43290837)
106. Bischoff J. R., Plowman G. D., The Aurora/Ipl1p kinase family: regulators of chromosome segregation and cytokinesis Trends in Cell Biology 1999 9 11 454 459 (Pubitemid 29469430)
107. Katayama H., Sasai K., Kawai H., Yuan Z. M., Bondaruk J., Suzuki F., Fujii S., Arlinghaus R. B., Czerniak B. A., Sen S., Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53 Nature Genetics 2004 36 1 55 62 (Pubitemid 38056208)
108. Drexler H. G., Matsuo Y., Malignant hematopoietic cell lines: in vitro models for the study of natural killer cell leukemia-lymphoma Leukemia 2000 14 5 777 782 (Pubitemid 30235051)
109. Zhao S., Tang Q. L., He M. X., Yang F., Wang H., Zhang W. Y., Jiang W., Wang X. L., Mo X. M., Li G. D., Liu W. P., A novel nude mice model of human extranodal nasal type NK/T-cell lymphoma Leukemia 2008 22 1 170 178